Recent Advances in Immunothrombosis and Thromboinflammation.

Area of Science:

• Immunology and Hematology
• Cardiovascular Research
• Pathophysiology

Background:

• Inflammation and thrombosis are distinct host responses to injury, crucial for pathogen defense and hemostasis, respectively.
• Dysregulated inflammation and thrombosis contribute to cardiovascular, autoimmune, and malignant diseases.
• The interplay between these processes, known as immunothrombosis and thromboinflammation, is increasingly recognized.

Purpose of the Study:

• To review recent insights into the complex relationship between inflammation and thrombosis.
• To explore the protective roles of immunothrombosis and the detrimental effects of thromboinflammation.
• To discuss the pathophysiology of thromboinflammation beyond COVID-19 and identify therapeutic targets.

Main Methods:

• Comprehensive review of recent scientific literature on inflammation and thrombosis.
• Focus on molecular mechanisms involving cellular players (neutrophils, monocytes, platelets) and plasma proteins.
• Analysis of signaling cascades and technological advancements in studying these interactions.

Main Results:

• Identified key molecular aspects of cellular and plasma protein involvement in immunothrombosis and thromboinflammation.
• Demonstrated how these factors promote detrimental thromboinflammation in cardiovascular, septic, and autoimmune diseases.
• Highlighted the role of new technologies and integrated clinical data in mechanistic investigations.

Conclusions:

• The interplay between inflammation and thrombosis is a critical factor in numerous diseases.
• Understanding immunothrombosis and thromboinflammation pathways is essential for developing novel therapeutics.
• Further research is needed to translate mechanistic insights into clinical applications for treating thromboinflammatory disorders.